Navigation Links
PRA Staff Named Finalists in Clinical Researcher of the Year Competition
Date:10/30/2013

RALEIGH, N.C., Oct. 30, 2013 /PRNewswire/ -- PRA, a leading clinical research organization, today announces that 22 employees have been named finalists in the 2013 Clinical Researcher of the Year competition. Fourteen employees represent PRA in the U.S. competition and eight employees represent PRA in the International competition.

The prestigious competition, organized by PharmaTimes, named PRA "Clinical Company of the Year" in 2012 based on the total points earned by its employees' performances in individual competitions. Last year, PRA staff members achieved two first-place prizes and two third-place prizes

PRA finalists in the 2013 U.S. competition for the "New CRA" category are Lee Steen, Maria Joshi, and Mercy Baker; the "Experienced CRA" category finalists are Jennifer Wiley and Susan Goodnough; the "Project Manager" category finalists are Promise Lawrence, Adrienne Stoudenmire, Sarah Connell, and Adam Cohen; and the "Team" category finalists are Denise Butler, Laura Hampshire, Dani Eaton, Denise Richard, and Heidi Miller.

PRA finalists in the International competition for the "Clinical Team" category are Alison Edwards, Clare Jeffery, Charlotte Craggs, and Angharad Smith; the "CRA" category finalist is Victoria Hawkins; the "CTA" category finalist is Ketaki Pathare; and the "Team Leader" category finalists are Emma Lewis and Justin Harvey.

The finals for the U.S. competition will take place Nov. 7, 2013, in Cary, N.C., at the global headquarters of SAS, a competition partner. An awards ceremony announcing the winners will take place later that day at the Umstead Hotel on the SAS campus.

The finals for the International competition will take place Nov. 13 and Nov. 28, 2013. An awards ceremony announcing the winners will take place Jan. 30, 2014, at 8 Northumberland Avenue, London.

About PRA

One of the world's largest CROs, PRA is transforming clinical trials through our people, innovation and operational transparency. Our 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Embedded clinical trial solutions that meet the demands of a diverse marketplace.

Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. Our forward-thinking approach to clinical research innovation, customized recruitment strategies and technological advances continues to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email clearlypra@praintl.com.


'/>"/>
SOURCE PRA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services
2. Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company
3. iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard
4. Western Maryland Health System Expands Use of Versus RTLS to Enhance Staff Safety
5. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
6. Medical Device Study Presents Detailed View of Key Budget and Staffing Metrics for Marketing Groups
7. Staffing and Performance Benchmarks for Regulatory Function Highlight New Medical Device Study
8. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
9. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
10. AbbVie Named a Science Top Employer
11. BioTrackTHC Named Washington States Legal Marijuana Traceability System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... and laboratory-grade deionized water from the same place. From 101 Water Texas, here ... Satisfaction: Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated ...
(Date:4/23/2017)... CA (PRWEB) , ... April 23, 2017 , ... ... solutions and managed services announced the achievement of Cisco Select certification and SMB ... throughout the United States. , In earning the Select Certification, Altura ...
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/22/2017)... PA (PRWEB) , ... April 22, 2017 , ... ... experience to his role as Vice President of Sales and Business Development at ... key GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... 21, 2017 , ... An April 10 article in the Daily ... reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, no ... to remove decayed dental matter, and that teeth were then filled with bitumen, a ...
Breaking Medicine News(10 mins):